APA

van der Wall E., Richel D. J., Kusumanto Y. H., Rutgers E. J., Schornagel J. H., Schaake-Koning C. C., Peterse J. L. & Rodenhuis S. (19940217). Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

van der Wall E, Richel D J, Kusumanto Y H, Rutgers E J, Schornagel J H, Schaake-Koning C C, Peterse J L and Rodenhuis S. 19940217. Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

van der Wall E., Richel D. J., Kusumanto Y. H., Rutgers E. J., Schornagel J. H., Schaake-Koning C. C., Peterse J. L. and Rodenhuis S. (19940217). Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

van der Wall E, Richel D J, Kusumanto Y H, Rutgers E J, Schornagel J H, Schaake-Koning C C, Peterse J L and Rodenhuis S. Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 19940217.